Last reviewed · How we verify
BCX-1777
At a glance
| Generic name | BCX-1777 |
|---|---|
| Sponsor | BioCryst Pharmaceuticals |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- BCX-1777 CI brief — competitive landscape report
- BCX-1777 updates RSS · CI watch RSS
- BioCryst Pharmaceuticals portfolio CI